Cancer Care
When cancer picks a fight, we fight back.
Learn More
Blood and Marrow Transplantation
The physicians at Indiana Blood and Marrow Transplantation (IBMT) pioneered the first transplant program for blood cancer in Indiana. This groundbreaking work, including cutting-edge research, is carried on today at Franciscan Health's Cancer Center in Indianapolis.
Our internationally recognized HLA-Vascular Biology Laboratory performs histocompatibility testing.
SPECIALIZED TRANSPLANT TESTING
Our Indianapolis hospital offers testing for bone marrow and stem cell donors.
{{headline}}
Blood and Marrow Transplantation
Nationally Recognized Blood and Morrow Transplant Services
Franciscan Health is the hospital partner for Indiana Blood and Marrow Transplantation (IBMT), which pioneered the first transplant program for blood cancer in Indiana. This groundbreaking work, including cutting-edge research, is carried on today at Franciscan Health's Cancer Center in Indianapolis.
IBMT is a research-oriented organization, providing patients with the best assets of both academic and private practice settings. While its physicians and staff are on the forefront of leading bone marrow transplant technology, the patient still has the benefit of being able to access fully credentialed physicians at any hour or day or night. IBMT is highly regarded nationally and was one of the first five programs in the nation accredited by the Foundation for Accreditation of Cellular Therapy (FACT). FACT accreditation demonstrates commitment to quality in cellular therapy and blood and marrow transplantation through adherence to rigorous standards, as verified by periodic inspections and peer review. Our nationally recognized physicians have performed hundreds of stem cell transplants in outpatient and inpatient settings. Indiana Blood and Marrow Transplantation provides you access to the latest research and clinical trials and specialized treatments.
IBMT has one of two photopheresis centers in Indiana. Patients with CTCl, organ rejection or Graft versus Host Disease can now be treated close to home in a personalized, convenient setting.
IBMT offers treatments for both autoloous and allogenic patients. Our unique outpatient clinic model enables eligible patients the opportunity to undergo the transplant process in the outpatient clinic during the day and stay at home or nearby local accomodations at night.
Apheresis is the process of extracting blood components from the peripheral blood with the help of an apheresis machine. This machine separates blood into its components on the basis of weight. The machine can be used to obtain plasma (the liquid of the blood), platelets or white blood cells.
Special blood tests, called Human Leukocyte Antigen (HLA) typing, determine whether a patient has a suitable donor for stem cell transplant or bone marrow transplant. HLA typing is increasingly done using DNA techniques and can take several days to complete. Nationally recognized cancer experts offer evaluations and advanced treatment options in our cancer second opinion clinic - helping you to receive the best treatment possible. CT (computed tomography) guided biopsies are used to test for cancer or infection. CT scan imaging guides where the needle is placed, during which the patient will need to lie still for about 30-60 minutes. The success rate of bone marrow transplants, organ transplants and pregnancies are all dependent on matching HLA. Franciscan Health has an expert lab focused on testing compatibility of Human Leukocyte Antigens. Non-Myeloablative transplant, also called "mini-transplant," is a stem cell transplant from a donor (allogeneic) that uses a less aggressive combination of chemotherapy and/or radiation to prepare the patient for the transplant.
Photopheresis is a procedure that might be recommended by your doctor to prevent or to treat graft versus host disease (GvHD). A blood and marrow stem cell transplant is a procedure that replaces a person's faulty stem cells with healthy ones.
Ultrasound guided biopsies use ultrasound imaging to guide needle placement to test for cancer or infection. This is most often used for testing breast tissue and abdominal organs.
IBMT's History
Indiana Blood and Marrow Transplantation is the name for the Stem Cell Transplant program which was established as a partnership between Cancer Center Associates and SpectraCare Management Services. Since 2006 the hospital partner has been Franciscan Health Indianapolis. The IBMT Outpatient Clinic and Administrative Offices are physically located in Franciscan Health Indianapolis. The new inpatient unit opened in 2012.
